AIDS 2014 Conference Highlight from Sharon Lewin [VIDEO]

As the 20th International AIDS Conference drew to a close in Melbourne, AIDS 2014 co-chair Sharon Lewin offered an overview of some highlights of the meeting at a Friday press briefing.


AIDS 2014: Weight Gain on ART May Raise Risk of Heart Disease and Diabetes

People with HIV who gain weight shortly after starting antiretroviral therapy (ART) may have an increased risk of cardiovascular disease and diabetes, according to findings from the D:A:D study presented this week at the 20th International AIDS Conference in Melbourne, Australia.


Coverage of the 2014 International AIDS Conference coverage of the 20th International AIDS Conference (AIDS 2014), July 20-25, in Melbourne, Australia.

Conference highlights include biomedical HIV prevention (PrEP and treatment-as-prevention), HIV cure research, interferon-free therapy for hepatitis C and HIV/HCV coinfection, access to treatment, and fighting stigma and criminalization of key affected populations.

Full listing by topic

AIDS 2014 website



AIDS 2014: Good Adherence Seen in IPERGAY Study of Intermittent PrEP

The first results from the IPERGAY study, a trial of pre-exposure prophylaxis (PrEP) in gay men taking place in France and Quebec, Canada, appear to indicate excellent adherence to a novel "pre-and-post" intermittent PrEP strategy designed to save money and reduce time spent taking PrEP unnecessarily. The results were presented at the 20th International AIDS Conference this week in Melbourne, Australia.


AIDS 2014: Criminalization of Sex Work Increases Vulnerability to HIV

Sex workers from more than 30 countries came together this week at the Sex Worker Pre-Conference preceding the 20th International AIDS Conference in Melbourne to consider proposed changes to policy and funding approaches aimed at positioning human rights as critical to the response to HIV/AIDS.


AIDS 2014: Melbourne Declaration -- Nobody Left Behind

Ending discrimination against and criminalization of people with HIV and at-risk populations including gay men, sex workers, transgender people, and people who use drugs is a fundamental component of the response to HIV/AIDS, according to the Melbourne Declaration, the official statement of the 20th International AIDS Conference taking place this week in Melbourne, Australia. Sign on to the declaration at


AIDS 2014: iPrEx OLE Confirms PrEP Works, but Many Don't Take It [VIDEO]

The open-label extension of the iPrEx study found that Truvada pre-exposure prophylaxis (PrEP) was highly The open-label extension of the iPrEx study found that Truvada pre-exposure prophylaxis (PrEP) was highly effective among gay men who took it regularly to prevent HIV, but many did not do so, researchers reported this week at the 20th International AIDS Conference in Melbourne.